Actress Lisa Ray has spoken candidly about experiencing early menopause triggered by chemotherapy, revealing that she entered menopause at the age of 37 — years ahead of the biological norm. The disclosure, shared through a post on Instagram, forms part of her broader advocacy for women's midlife and hormonal health.

What Lisa Ray Shared

In her post, Ray described how chemotherapy — administered as part of her treatment for multiple myeloma, a rare blood cancer she was diagnosed with in 2009 — pushed her body across the threshold of menopause with little warning or support. 'I went into menopause at 37. Chemotherapy pushed my body across that threshold, and I found myself with very little understanding of what was happening,' she wrote.

She added that, like many women, she spent years simply adapting rather than fully grasping what the physiological changes meant for her overall wellbeing. 'Survival and wellbeing are not the same thing,' she noted pointedly.

The Silence Around Menopause

Ray drew on a 2025 Indian study that surveyed more than 32,000 women from under-resourced communities to underscore the scale of the awareness gap. According to the study, half of those surveyed were unaware of the effects of menopause, and 62% did not know that treatment options existed. 'This is an epidemic of silence and inadequate care that we are only now waking up to,' she wrote.

The actress described this silence as 'almost as difficult to navigate as the symptoms themselves' — a sentiment that shaped her decision to take action beyond personal advocacy.

Co-Founding NuHer

Ray revealed that her experience directly motivated her to co-found NuHer, a platform dedicated to women's midlife and hormonal health. 'I wanted to help build what I couldn't find at 37: a place dedicated to women's midlife and hormonal health,' she explained. Through the platform, she aims to shift the healthcare conversation for women from passive endurance to informed, evidence-based care.

She described the shift she hopes to catalyse — from dismissive responses like 'It's your age' to 'Let's understand what's happening,' and from 'Learn to live with it' to 'Let's look at the evidence and your individual health story.'

Background: Lisa Ray's Cancer Diagnosis

Ray was diagnosed with multiple myeloma in 2009 — a rare and incurable form of blood cancer that affects the plasma cells. Her chemotherapy treatment, while life-saving, carried long-term consequences including the premature onset of menopause. She has since become a prominent voice on women's health, survivorship, and the often-overlooked complexities of post-treatment life.

What This Signals for Women's Health

Ray's disclosure arrives at a moment when menopause is gaining long-overdue attention in public health discourse in India and globally. Notably, the 2025 study she cited points to a systemic failure — not merely individual ignorance — in how menopause is communicated and managed within healthcare systems, particularly for women in under-resourced settings. As research grows and advocacy voices like Ray's amplify the conversation, the pressure on healthcare providers and policymakers to respond is intensifying.